Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Loof NM"'
Autor:
Verdegaal EME; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands e.m.e.verdegaal@lumc.nl., Santegoets SJ; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Welters MJP; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., de Bruin L; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Visser M; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., van der Minne CE; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., de Kok PM; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Loof NM; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Boekestijn S; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Roozen I; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Westra IM; Center for Cell and Gene Therapy, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Meij P; Center for Cell and Gene Therapy, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Van der Burg SH; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Kroep JR; Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Nov; Vol. 11 (11).
Autor:
Gosens KCM; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Dermatology, Amsterdam Institute for Infection and Immunity (AI&II), Amsterdam, the Netherlands., van der Burg SH; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Welters MJP; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Boekestijn S; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Loof NM; Leiden University Medical Center, Department of Medical Oncology, Oncode Institute, Leiden, the Netherlands., Quint WGV; DDL Diagnostic Laboratory, Rijswijk, the Netherlands., van Noesel CJM; Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands., van der Wal AC; Amsterdam UMC, University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands., Richel O; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.; Radboud University Medical Center, Department of Internal Medicine, Nijmegen, the Netherlands., Krebber WJTA; ISA Pharmaceuticals, Oegstgeest, the Netherlands., Melief CJM; ISA Pharmaceuticals, Oegstgeest, the Netherlands., de Vries HJC; Amsterdam UMC, University of Amsterdam, Department of Dermatology, Amsterdam Institute for Infection and Immunity (AI&II), Amsterdam, the Netherlands.; STI outpatient clinic, Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, the Netherlands., Prins JM; Amsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 13; Vol. 29 (20), pp. 4109-4117.
Autor:
Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Welters MJP; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Poelgeest MIE; Department of Gynaecology, Leiden University Medical Center, Leiden, The Netherlands., de Vos van Steenwijk PJ; Department of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, The Netherlands., Roozen I; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Boekestijn S; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Loof NM; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Zom GG; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Valentijn ARPM; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Krebber WJ; ISA Pharmaceuticals B.V, Oegstgeest, The Netherlands., Meeuwenoord NJ; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Janssen CAH; Department of Gynaecology, Groene Hart Ziekenhuis, Gouda, The Netherlands., Melief CJM; ISA Pharmaceuticals B.V, Oegstgeest, The Netherlands., van der Marel GA; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., Filippov DV; Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands., van der Burg SH; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Ossendorp F; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands F.A.Ossendorp@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).
Autor:
Duurland CL; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Santegoets SJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Abdulrahman Z; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Loof NM; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Sturm G; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Wesselink TH; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Arens R; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Boekestijn S; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Ehsan I; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van Poelgeest MIE; Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands., Finotello F; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.; Institute of Molecular Biology, University of Innsbruck, Innsbruck, Austria.; Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria., Hackl H; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Trajanoski Z; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Ten Dijke P; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., Braud VM; Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, Université Côte d'Azur, UMR7275, 06560 Valbonne, Sophia Antipolis, France., Welters MJP; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
Autor:
Otterhaug T; PCI Biotech AS, Oslo, Norway., Janetzki S; ZellNet Consulting, Inc., Fort Lee, NJ, United States., Welters MJP; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Håkerud M; PCI Biotech AS, Oslo, Norway.; Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Nedberg AG; PCI Biotech AS, Oslo, Norway.; Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Edwards VT; PCI Biotech AS, Oslo, Norway.; Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Boekestijn S; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Loof NM; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Selbo PK; Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Olivecrona H; PCI Biotech AS, Oslo, Norway., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, Netherlands., Høgset A; PCI Biotech AS, Oslo, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Jan 08; Vol. 11, pp. 576756. Date of Electronic Publication: 2021 Jan 08 (Print Publication: 2020).
Autor:
Santegoets SJ; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Duurland CL; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Jordanova EJ; Department of Obstetrics and Gynecology, Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC - Locatie VUMC, Amsterdam, Noord-Holland, The Netherlands., van Ham VJ; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Ehsan I; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Loof NM; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Narang V; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore., Dutertre CA; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore., Ginhoux F; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore., van Egmond SL; Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands., J P Welters M; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Aug; Vol. 8 (2).
Autor:
Melief CJM; ISA Pharmaceuticals, J.H. Oortweg 19, 2333 CH Leiden, Netherlands. melief@isa-pharma.com shvdburg@lumc.nl.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands., Welters MJP; Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands., Vergote I; Department of Gynecologic Oncology, University Hospital, Leuven Cancer Institute, UZ Herestraat 49, 3000 Leuven, Belgium., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands., Kenter GG; Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands., Ottevanger PB; Department of Medical Oncology, Nijmegen University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, Netherlands., Tjalma WAA; Multidisciplinary Breast Clinic-Unit Gynecological Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium., Denys H; Department of Medical Oncology, University Hospital, De Pintelaan 185, 9000 Gent, Belgium., van Poelgeest MIE; Department of Gynecology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands., Nijman HW; Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, Netherlands., Velu T; Chirec Cancer Institute, Medical Centre Edith Cavell, Rue Edith Cavell 32, 1180 Brussels, Belgium., Goffin F; Chirec Cancer Institute, Medical Centre Edith Cavell, Rue Edith Cavell 32, 1180 Brussels, Belgium., Lalisang RI; Department of Medical Oncology, GROW School of Oncology and Developmental Biology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, Netherlands., Loof NM; Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands., Boekestijn S; Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands., Krebber WJ; ISA Pharmaceuticals, J.H. Oortweg 19, 2333 CH Leiden, Netherlands., Hooftman L; ISA Pharmaceuticals, J.H. Oortweg 19, 2333 CH Leiden, Netherlands., Visscher S; ISA Pharmaceuticals, J.H. Oortweg 19, 2333 CH Leiden, Netherlands., Blumenstein BA; Trial Architecture Consulting, 4703 Morgan Dr., Chevy Chase, MD 20815, USA., Stead RB; BioPharma Consulting Services, 691 96th Avenue Southeast, Bellevue, WA 98004, USA., Gerritsen W; Department of Medical Oncology, Nijmegen University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, Netherlands., van der Burg SH; Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, Netherlands. melief@isa-pharma.com shvdburg@lumc.nl.; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, Netherlands.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 Mar 18; Vol. 12 (535).
Autor:
van Meir H; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands; Centre for Human Drug Research, Leiden, the Netherlands., Nout RA; Department of Radiation Oncology, Leiden University Medical Center , Leiden, the Netherlands., Welters MJ; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands., Loof NM; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands., de Kam ML; Centre for Human Drug Research , Leiden, the Netherlands., van Ham JJ; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands., Samuels S; Center Gynecological Oncology Amsterdam , NKI-AvL , Amsterdam, the Netherlands., Kenter GG; Center Gynecological Oncology Amsterdam , NKI-AvL , Amsterdam, the Netherlands., Cohen AF; Centre for Human Drug Research , Leiden, the Netherlands., Melief CJ; ISA Pharmaceuticals , Leiden, the Netherlands., Burggraaf J; Centre for Human Drug Research , Leiden, the Netherlands., van Poelgeest MI; Department of Gynecology, Leiden University Medical Center , Leiden, the Netherlands., van der Burg SH; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 Dec 23; Vol. 6 (2), pp. e1267095. Date of Electronic Publication: 2016 Dec 23 (Print Publication: 2017).
Autor:
Talebian Yazdi M; Department of Pulmonology, Leiden University Medical Center , Leiden, the Netherlands., Schinkelshoek MS; Department of Pulmonology, Leiden University Medical Center , Leiden, the Netherlands., Loof NM; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands., Taube C; Department of Pulmonology, Leiden University Medical Center , Leiden, the Netherlands., Hiemstra PS; Department of Pulmonology, Leiden University Medical Center , Leiden, the Netherlands., Welters MJ; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands., van der Burg SH; Department of Medical Oncology, Leiden University Medical Center , Leiden, the Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 Nov 08; Vol. 5 (12), pp. e1255393. Date of Electronic Publication: 2016 Nov 08 (Print Publication: 2016).
Autor:
Zom GG; Department of Immunohematology and Blood Transfusion, Section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., Welters MJ; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Loof NM; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Goedemans R; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Lougheed S; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Valentijn RR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Zandvliet ML; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Meeuwenoord NJ; Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands., Melief CJ; Department of Immunohematology and Blood Transfusion, Section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands.; ISA Pharmaceuticals BV, Leiden, The Netherlands., de Gruijl TD; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Van der Marel GA; Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands., Filippov DV; Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands., Ossendorp F; Department of Immunohematology and Blood Transfusion, Section Tumorimmunology, Leiden University Medical Center, Leiden, The Netherlands., Van der Burg SH; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2016 Oct 11; Vol. 7 (41), pp. 67087-67100.